| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/07/2004 | CN1486702A Injection for eliminating wrinkles and scar and its prepn |
| 04/07/2004 | CN1486699A Application of the effective part of Chinese medicinal material lindley eupatorium herb in preparing antiviral medicine |
| 04/07/2004 | CN1486698A Solid oral preparation containing melbine and Glibenclamide |
| 04/07/2004 | CN1486697A Cream for treating keratosis and chap |
| 04/07/2004 | CN1486696A Freeze dried pirenzepine powder for injection |
| 04/07/2004 | CN1486695A Delayed releasing Acipimox prepn |
| 04/07/2004 | CN1486694A Cancer treating medicine |
| 04/07/2004 | CN1486693A Prepn and product of oxiracetam powder for injection |
| 04/07/2004 | CN1486690A Medicinal salt with local narcosis and antiphlogosis activity and its prepn process |
| 04/07/2004 | CN1486689A Propranolol hydrochloride dripping pill and its prepn |
| 04/07/2004 | CN1486687A Dragees |
| 04/07/2004 | CN1486686A Stomach floating pulsed releasing tablet |
| 04/07/2004 | CN1144598C Stabilization of compositions containing ACE inhibitors using magnesium oxide |
| 04/07/2004 | CN1144594C External-use plaster for softening dry feces and dissipating mass |
| 04/07/2004 | CN1144592C Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 04/07/2004 | CN1144590C Low side-effect compound gentamicin preparation |
| 04/07/2004 | CN1144585C Animal fast biochemical accelerating composition containing cysteamine and its salt and use |
| 04/07/2004 | CN1144584C Sustained-release compositions and method for preparing the same |
| 04/07/2004 | CN1144583C Micella nanoparticles |
| 04/07/2004 | CN1144582C Medical aerosol without freon for treating respiratory system diseases |
| 04/07/2004 | CN1144577C Preparation process and equipment for Chinese medicine tublet for treating coronary heart disease |
| 04/06/2004 | US6717015 Venlafaxine besylate |
| 04/06/2004 | US6716970 Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof |
| 04/06/2004 | US6716884 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof |
| 04/06/2004 | US6716883 Especially induced by smoking; administering an aryl hydrocarbon receptor antagonist, resveratrol |
| 04/06/2004 | US6716882 Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
| 04/06/2004 | US6716877 Method to treat chronic heart failure and/or elevated cholesterol levels |
| 04/06/2004 | US6716868 (-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/06/2004 | US6716830 For therapy and prophylaxis of ophthalmic, otic or nasal infections and attendant inflammation |
| 04/06/2004 | US6716828 Treatment or prevention of neural or cardiovascular tissue damage related to cerebral ischemia and reperfusion injury in an animal by administering poly(adp- ribose) polymerase (?parp?) inhibitors. |
| 04/06/2004 | US6716819 Exposing infectious microbial cells to endogenous antimicrobials in bodily fluids by contacting body surfaces which secrete these bodily fluids with an effective amount of non-ionic osmolytes with low transepithelial permeability |
| 04/06/2004 | US6716817 Method of treatment of female infertility |
| 04/06/2004 | US6716816 Dyslipidemia, hypercholesterolemia, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock. |
| 04/06/2004 | US6716815 Comprises whey/soy protein, casein-polypeptide, fatty acid, and insoluble vegetable/fruit fiber which stimulates cholecystokinin levels for better regulation of glucose and insulin levels following meal consumption; diabetes |
| 04/06/2004 | US6716812 Calcitonin promotes fertilizing ability in mammalian sperm and is useful for treatment of conditions of low fertility in humans and animals |
| 04/06/2004 | US6716456 Combining particles of insoluble substrate with membrane forming ionic polymer and aqueous buffer solution with high ionic strength, forming coacervate by adding water binding agent to form aqueous complex and cause phase separation |
| 04/06/2004 | US6716455 Aqueous solution containign surfactant mixture |
| 04/06/2004 | US6716454 Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof |
| 04/06/2004 | US6716453 Determining compression formulation including active ingredients and non-active hardening or binder excipients, preparing revised formulation with excipient replaced with abrupt pressure treated polysaccharide, compressing mixture |
| 04/06/2004 | US6716452 Active agent delivery systems and methods for protecting and administering active agents |
| 04/06/2004 | US6716451 Formulation for vitamin e doses with increased antioxidant capacity comprising d-alpha-tocopherol, dl-alpha-tocopherol, mixed tocopherols, and tocotrienols in forms comprising inseparable tocopherols |
| 04/06/2004 | US6716450 Nanocapsule having core-shell structure, consisting essentially of randomly branched hydrophilic polymer having hydrophobic chain-end moieties, and bioactive molecule encapsulated within nanocapsule |
| 04/06/2004 | US6716449 Dosage form; antagonist to attenuate a side effect of said opioid agonist; analgesia for at least about eight hours when administered to human patients |
| 04/06/2004 | US6716447 Stable carotene xanthophyll beadlet compositions and methods of use |
| 04/06/2004 | US6716445 Time-release agents, therapy, drug delivery |
| 04/06/2004 | US6716438 Use of nanoscalar antimicrobial active ingredients in body deodorants |
| 04/06/2004 | US6716418 Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 04/06/2004 | US6716417 Condensation of heated vapor to form aerosol particles |
| 04/06/2004 | US6716416 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of an antipsychotic such as olanzapine, trifluoperazine, haloperidol, loxapine, clozapine, quetiapine, promazine, etc. |
| 04/06/2004 | US6716415 An aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of a sedative-hypnotic, such as zaleplon, zolpidem or zopiclone. |
| 04/06/2004 | US6716414 Aerosol solution for use in an aerosol inhaler |
| 04/06/2004 | US6716251 Implant for subcutaneous or intradermal injection |
| 04/06/2004 | US6716208 Implantable device and use therefor |
| 04/06/2004 | CA2306005C Gel preparation containing polystyrene-sulfonates |
| 04/06/2004 | CA2225521C Laser assisted drug delivery apparatus |
| 04/06/2004 | CA2171294C Viscous surfactant emulsion compositions |
| 04/01/2004 | WO2004027897A1 Method for manufacture of films containing insoluble solids embedded in cellulose-based films |
| 04/01/2004 | WO2004027822A2 Oriented nanostructures and methods of preparing |
| 04/01/2004 | WO2004027383A2 System and method to stress test aerosol inhalation devices |
| 04/01/2004 | WO2004027372A2 Method for diagnosing rhabdomyosarcoma and pharmaceutical compositions for the treatment and/or prevention of rhabdomyosarcoma |
| 04/01/2004 | WO2004027044A2 Triplex hairpin ribozyme |
| 04/01/2004 | WO2004026950A2 Solid flowable powder with high liquid loading |
| 04/01/2004 | WO2004026941A1 Drug delivery |
| 04/01/2004 | WO2004026912A1 Solubilising polysaccharides substituted with hydrophilic and hydrophobic groups |
| 04/01/2004 | WO2004026834A1 Crystalline organic acid salt of amlodipine |
| 04/01/2004 | WO2004026457A1 Process for producing microcapsule |
| 04/01/2004 | WO2004026453A2 Microcapsules and methods of use |
| 04/01/2004 | WO2004026374A1 Programmable dose control module |
| 04/01/2004 | WO2004026362A2 Dri nasal sprays |
| 04/01/2004 | WO2004026351A2 Improved ion triggerable, cationic polymers, a method of making same and items using same |
| 04/01/2004 | WO2004026345A1 Control of nitric oxide bioactivity by perfluorocarbons |
| 04/01/2004 | WO2004026336A1 Improvements in or relating to vaccines |
| 04/01/2004 | WO2004026335A1 Pharmaceutical composition comprising carriers for products |
| 04/01/2004 | WO2004026320A1 Vitreoretinal tamponades based on fluorosilicone fluids |
| 04/01/2004 | WO2004026314A1 Modified release formulations of oxcarbazepine and derivatives thereof |
| 04/01/2004 | WO2004026313A1 Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
| 04/01/2004 | WO2004026309A1 Effervescent formulations comprising apomorphine |
| 04/01/2004 | WO2004026308A1 Sustained release compound of acetamidophenol and tramadol |
| 04/01/2004 | WO2004026288A1 A treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells |
| 04/01/2004 | WO2004026284A1 Non gelatin films with improved barrier properties |
| 04/01/2004 | WO2004026283A1 Sequestering subunit and related compositions and metohds |
| 04/01/2004 | WO2004026282A1 Thermolabile liposome with a controlled release temperature |
| 04/01/2004 | WO2004026281A2 Micro-reservoir osmotic release systems and microtube array device |
| 04/01/2004 | WO2004026280A2 Granulate formulation of the rapamycin ester cci-779 |
| 04/01/2004 | WO2004026279A1 Effervescent formulations of oxytocin |
| 04/01/2004 | WO2004026278A1 Copolymer and hemoprotein based novel compounds and uses thereof |
| 04/01/2004 | WO2004026262A2 Abuse-resistant pharmaceutical compositions |
| 04/01/2004 | WO2004026261A2 Composition containing ribavirin and use thereof |
| 04/01/2004 | WO2004026259A2 Transdermal compositions |
| 04/01/2004 | WO2004026257A2 Treatment of irritable bowel syndrome and related bowel diseases |
| 04/01/2004 | WO2004026256A2 Sustained-release opioid formulations and methods of use |
| 04/01/2004 | WO2004026241A2 Multistage formulation containing a biguanide and thiazolidindione derivatives |
| 04/01/2004 | WO2004026235A2 Pharmaceutical compositions with improved dissolution |
| 04/01/2004 | WO2004026233A2 Mannitol formulation for integrin receptor antagonist |
| 04/01/2004 | WO2004026231A2 Formulation for lipophilic agents |
| 04/01/2004 | WO2004026196A1 A delivery system and a manufacturing process of a delivery system |
| 04/01/2004 | WO2004026118A2 Administration of free radical scavengers to prevent or treat ischemia-reperfusion injuries |
| 04/01/2004 | WO2004018681A3 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 04/01/2004 | WO2004017998A3 Topical emulsion- gel composition comprising diclofenac sodium |
| 04/01/2004 | WO2004014639A3 An apparatus for bench scale tablet-making |